These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7307016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Cutaneous side effects of antitumor chemotherapy].
    Delaunay M.
    Ann Dermatol Venereol; 1989 Feb; 116(4):347-61. PubMed ID: 2528934
    [No Abstract] [Full Text] [Related]

  • 6. Mucocutaneous side effects of Brequinar sodium. A new inhibitor of pyrimidine de novo biosynthesis.
    Schwartsmann G, Bork E, Vermorken JB, Nieboer C, Dodion P, ten Bokkel Huinink WW, Seldenrijk CA, Armand JP, Pinedo HM.
    Cancer; 1989 Jan 15; 63(2):243-8. PubMed ID: 2521297
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Tissue necrosis caused by careless injection of cytostatic agents].
    Klepp O, Kvaløy S.
    Tidsskr Nor Laegeforen; 1978 Sep 30; 98(27):1330-1. PubMed ID: 694872
    [No Abstract] [Full Text] [Related]

  • 9. [Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
    Schubert JC, Martin H.
    Munch Med Wochenschr; 1968 Jan 12; 110(2):97-100. PubMed ID: 5695132
    [No Abstract] [Full Text] [Related]

  • 10. Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.
    Gore SD, Weng LJ, Zhai S, Figg WD, Donehower RC, Dover GJ, Grever M, Griffin CA, Grochow LB, Rowinsky EK, Zabalena Y, Hawkins AL, Burks K, Miller CB.
    Clin Cancer Res; 2001 Aug 12; 7(8):2330-9. PubMed ID: 11489809
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Easing the unwanted effects of chemotherapy.
    Johns Hopkins Med Lett Health After 50; 2007 Feb 12; 18(12):4-5. PubMed ID: 17340748
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase I-II trial of high-dose epirubicin in patients with lymphoma.
    Case DC, Gams R, Ervin TJ, Boyd MA, Oldham FB.
    Cancer Res; 1987 Dec 01; 47(23):6393-6. PubMed ID: 3479245
    [Abstract] [Full Text] [Related]

  • 19. Management of chemotherapy-induced stomatitis.
    Wojtaszek C.
    Clin J Oncol Nurs; 2000 Dec 01; 4(6):263-70. PubMed ID: 11899324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.